Manyin Zheng

Manyin Zheng

Auto-generated profile, based on publicly available information

Manyin Zheng

School of Medicine, Shenzhen University Health Science Center, Shenzhen, 518060, Guangdong, People's Republic of China.

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2015 in Chinese Journal of Cancer
Verified
Journal Article
Open access
PDF file
MZMeiqi Zeng
Meiqi Zeng
MZManyin Zheng
Manyin Zheng
DLDesheng LU
Desheng LU
JWJun Wang
Jun Wang
WJWenqi Jiang
Wenqi Jiang
OSOu Sha
Ou Sha
Ribosome-inactivating proteins (RIPs) belong to a family of enzymes that attack eukaryotic ribosomes and potently inhibit cellular protein synthesis. RIPs possess several biomedical properties, including anti-viral and anti-tumor activities. Multiple RIPs are known to inhibit tumor cell proliferation through inducing apoptosis in a variety of cancers, such as breast cancer, leukemia/lymphoma, and hepatoma. This review focuses on the anti-tumor activities of RIPs and their apoptotic effects through three closely related pathways: mitochondrial, death receptor, and endoplasmic reticulum pathways.